RORone Peterson Cerqueira Oliveira

Rone Peterson Cerqueira Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rone Peterson Cerqueira Oliveira has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Iron deficiency anemia in pregnancy: prevention, diagnosis and treatment: Number 5 – 2026

    by Carlos Alberto Maganha, Antonio Alceu dos Santos, Carolina Carvalho Mocarzel, Rone Peterson Cerqueira Oliveira, Isabel Cristina Céspedes, Rosiane Mattar

  • Anemia ferropriva na gestação: prevenção, diagnóstico e tratamento Número 5 – 2026

    by Carlos Alberto Maganha, Antonio Alceu dos Santos, Carolina Carvalho Mocarzel, Rone Peterson Cerqueira Oliveira, Isabel Cristina Céspedes, Rosiane Mattar

  • Prevalence of Chlamydia trachomatis endocervical infection in systemic lupus erythematosus patients and evaluation of the risk for HPV-induced lesions

    by Licia CostaPinto, Viviana Gallazzi Olavarria, Maria Fernanda Rios Grassi, Leomar D’ Cirqueira Lyrio, Rone Peterson Cerqueira Oliveira, Iuri Usêda Santana, Cristiane Bahiana Cruz, Mittermayer Barreto Santiago

    Chlamydia trachomatis (CT) is the most common bacterial cause of sexually transmitted disease. It has been associated with arthritis and it is a risk factor for human papillomavirus (HPV)-induced lesions. There are few studies on the frequency of CT infection among systemic lupus erythematosus (SLE) patients. The aim of this study was to determine the prevalence of endocervical CT infection among SLE patients and evaluate whether or not CT infection is a risk factor for HPV-induced lesions. A cross-sectional study included a group of patients who fulfilled the American College Rheumatology criteria for a definite diagnosis of SLE and a control group of non-SLE female individuals from Bahia, Brazil. Polymerase chain reaction was used on endocervical swab specimens to test for CT; a gynecological examination including a cervical cytology and biopsy was done for the identification of HPV lesions. A total of 105 SLE patients were studied, and the control group was composed of 104 age-matched apparently normal women. The prevalence of CT endocervical infection was 3.0 % [confidence interval (CI) 95 % = 0.6–8.0 %] in the SLE group and 5.0 % (95 % CI = 2.0–11.0 %) in the control group; the prevalence ratio was 0.60 (95 % CI = 0.1–2.5). The prevalence of vulvar condyloma was higher among SLE patients (11.0 vs. 1.0 %, p < 0.001), as were the prevalences of low-grade lesion (12.0 vs. 1.0 %, p < 0.001) and cervical intraepithelial neoplasia 1 (9.0 vs. 1.0 %, p = 0.02). There was no association between the presence of HPV lesions and CT infections. However, the small number of patients with CT prevents a definite conclusion from being drawn. The prevalence of endocervical CT infection in women with SLE is low and similar to that of the normal population. This suggests that this infection has no role in the pathogenesis of SLE or the development of HPV-induced lesions.


  • Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus

    by Leomar D. C. Lyrio, Maria Fernanda R. Grassi, Iuri U. Santana, Viviana G. Olavarria, Aline Do N. Gomes, Licia CostaPinto, Rone Peterson C. Oliveira, Rita de Cássia R. Aquino, Mittermayer B. Santiago

    Genital infection by human papillomavirus (HPV) tends to occur more frequently in patients with conditions associated with immune suppression. Systemic lupus erythematosus (SLE) is an immunological disorder characterized by generalized inflammation and a number of clinical manifestations and circulating autoantibodies. The aim of the present study was to determine the prevalence of genital HPV infection among female SLE patients. Women diagnosed with SLE based on American College of Rheumatology classification criteria followed at rheumatology outpatient clinic of the Escola Bahiana de Medicina e Saude Publica, Salvador, Brazil, were included in the study. As a comparison group, clinically healthy women who were attending the gynecology outpatient clinic for routine examination at the same institution were recruited. Testing for cervical HPV infection was performed using the nested polymerase chain reaction technique. Eighty-eight female SLE patients (mean age, 41.4 ± 11.6 years) and seventy healthy female subjects (control group) were studied. The prevalence of HPV infection was 80.7 % (71/88) in the SLE group and 35.7 % (25/70) in the control group (p < 0.0001). After adjustment of the variables (early sexual activity, number of partners and obstetric history), the odds ratio (OR) for genital HPV infection in women with SLE was 7.2 (95 % CI, 2.9 to 17.8; p = 0.0001). The use of immunosuppressive drugs was not associated with a higher prevalence of HPV infection. This study demonstrated that SLE patients have a higher prevalence of genital HPV infection, even when exposed to less potential risk factors for the virus.


  • Open Access

    Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil

    by Paula Matos Oliveira, Rita Elizabeth Mascarenhas, Claire Lacroix, Suzana Ramos Ferrer, Rone Peterson C. Oliveira, Elaine Andrade Cravo, André P. Ribeiro Alves, Maria Fernanda Rios Grassi


  • Open Access

    Vulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana

    by Paula Matos Oliveira, Rita Elizabeth Mascarenhas, Suzana Ramos Ferrer, Rone Peterson Cerqueira Oliveira, Iane Érica Marques Travessa, Marques Vinícius de Castro Gomes, Maria Fernanda Rios Grassi

    OBJETIVO: comparar a freqüência de vulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana (HIV) com mulheres não infectadas. MÉTODOS: estudo de corte transversal com 64 mulheres infectadas pelo HIV e 76 não infectadas. Foram calculadas as freqüências de vaginose bacteriana, candidíase e tricomoníase, que foram diagnosticadas por critérios de Amsel, cultura e exame a fresco, respectivamente. Para análise dos dados, utilizaram-se o teste do c2, teste exato de Fisher e regressão múltipla para verificar a independência das associações. RESULTADOS: a infecção vaginal foi mais prevalente em pacientes infectadas pelo HIV quando comparadas ao Grupo Controle (59,4 versus 28,9%, p<0,001; Odds Ratio=2,7, IC95%=1,33-5,83, p=0,007). Vaginose bacteriana ocorreu em 26,6% das mulheres HIV positivas; candidíase vaginal, em 29,7% e tricomoníase, em 12,5%. Todas foram significativamente mais freqüentes no grupo de mulheres infectadas pelo HIV (p=0,04, 0,02 e 0,04, respectivamente). CONCLUSÕES: vulvovaginites são mais freqüentes em mulheres infectadas pelo HIV.